Characterisation of age and polarity at onset in bipolar disorder.


Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
12 2021
Historique:
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 14 4 2022
Statut: ppublish

Résumé

Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools. To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics. Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts. Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = -0.34 years, s.e. = 0.08), major depression (β = -0.34 years, s.e. = 0.08), schizophrenia (β = -0.39 years, s.e. = 0.08), and educational attainment (β = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO. AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.

Sections du résumé

BACKGROUND
Studying phenotypic and genetic characteristics of age at onset (AAO) and polarity at onset (PAO) in bipolar disorder can provide new insights into disease pathology and facilitate the development of screening tools.
AIMS
To examine the genetic architecture of AAO and PAO and their association with bipolar disorder disease characteristics.
METHOD
Genome-wide association studies (GWASs) and polygenic score (PGS) analyses of AAO (n = 12 977) and PAO (n = 6773) were conducted in patients with bipolar disorder from 34 cohorts and a replication sample (n = 2237). The association of onset with disease characteristics was investigated in two of these cohorts.
RESULTS
Earlier AAO was associated with a higher probability of psychotic symptoms, suicidality, lower educational attainment, not living together and fewer episodes. Depressive onset correlated with suicidality and manic onset correlated with delusions and manic episodes. Systematic differences in AAO between cohorts and continents of origin were observed. This was also reflected in single-nucleotide variant-based heritability estimates, with higher heritabilities for stricter onset definitions. Increased PGS for autism spectrum disorder (β = -0.34 years, s.e. = 0.08), major depression (β = -0.34 years, s.e. = 0.08), schizophrenia (β = -0.39 years, s.e. = 0.08), and educational attainment (β = -0.31 years, s.e. = 0.08) were associated with an earlier AAO. The AAO GWAS identified one significant locus, but this finding did not replicate. Neither GWAS nor PGS analyses yielded significant associations with PAO.
CONCLUSIONS
AAO and PAO are associated with indicators of bipolar disorder severity. Individuals with an earlier onset show an increased polygenic liability for a broad spectrum of psychiatric traits. Systematic differences in AAO across cohorts, continents and phenotype definitions introduce significant heterogeneity, affecting analyses.

Identifiants

pubmed: 35048876
doi: 10.1192/bjp.2021.102
pii: S0007125021001021
pmc: PMC8636611
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-669

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH104964
Pays : United States
Organisme : Medical Research Council
ID : G1000708
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH124873
Pays : United States
Organisme : NIMH NIH HHS
ID : K99 MH116115
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH123451
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113078
Pays : United States
Organisme : NIMH NIH HHS
ID : R00 MH116115
Pays : United States

Références

Sci Adv. 2016 Jun 17;2(6):e1501678
pubmed: 27386562
Psychol Med. 2012 Jul;42(7):1383-96
pubmed: 22053816
Psychol Med. 2016 Mar;46(4):807-18
pubmed: 26621616
Am J Psychiatry. 2006 Oct;163(10):1754-9
pubmed: 17012686
Nat Genet. 2020 Apr;52(4):437-447
pubmed: 32231276
Int J Bipolar Disord. 2017 Dec;5(1):28
pubmed: 28480486
Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):949-962
pubmed: 30267149
J Clin Psychiatry. 2012 Apr;73(4):e561-6
pubmed: 22579163
Schizophr Res. 2014 Apr;154(1-3):48-53
pubmed: 24581549
Biol Psychiatry. 2020 Jul 15;88(2):169-184
pubmed: 31926635
Lancet. 2016 Jan 9;387(10014):156-67
pubmed: 26490195
Neuropsychobiology. 2010;62(1):72-8
pubmed: 20453537
Br J Psychiatry. 2008 Feb;192(2):150-1
pubmed: 18245035
Arch Gen Psychiatry. 1987 May;44(5):441-7
pubmed: 3579495
PLoS One. 2014 Aug 11;9(8):e104326
pubmed: 25111785
J Affect Disord. 2018 Jan 15;226:45-51
pubmed: 28961441
JAMA Neurol. 2014 Nov;71(11):1394-404
pubmed: 25199842
Psychol Med. 2019 Sep;49(12):2036-2048
pubmed: 30303059
Am J Med Genet C Semin Med Genet. 2003 Nov 15;123C(1):48-58
pubmed: 14601036
Am J Med Genet B Neuropsychiatr Genet. 2019 Mar;180(2):89-102
pubmed: 30070057
JAMA Psychiatry. 2017 Aug 1;74(8):841-847
pubmed: 28678992
Bipolar Disord. 2020 Mar;22(2):174-181
pubmed: 31628696
Psychol Med. 2011 Aug;41(8):1567-77
pubmed: 20836910
Can J Psychiatry. 2017 Apr;62(4):247-258
pubmed: 27462036
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
Biol Psychiatry. 2004 May 1;55(9):875-81
pubmed: 15110730
Lancet Neurol. 2017 Jun;16(6):445-451
pubmed: 28434855
Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):370-8
pubmed: 21305692
Bipolar Disord. 2019 Feb;21(1):68-75
pubmed: 29956436
Cell. 2018 Jun 14;173(7):1705-1715.e16
pubmed: 29906448
J Affect Disord. 2007 Nov;103(1-3):181-6
pubmed: 17324469

Auteurs

Janos L Kalman (JL)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; and International Max Planck Research School for Translational Psychiatry, Germany.

Loes M Olde Loohuis (LM)

Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, USA.

Annabel Vreeker (A)

Department of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre-Sophia Children's Hospital, the Netherlands.

Andrew McQuillin (A)

Division of Psychiatry, University College London, UK.

Eli A Stahl (EA)

Division of Psychiatric Genomics, Mount Sinai School of Medicine, USA.

Douglas Ruderfer (D)

Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt University Medical Center, USA; Department of Biomedical Informatics, Vanderbilt University Medical Center, USA; and Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, USA.

Maria Grigoroiu-Serbanescu (M)

Alexandru Obregia Clinical Psychiatric Hospital, Bucharest, Romania.

Georgia Panagiotaropoulou (G)

Department of Psychiatry and Psychotherapy, Charite - Universitätsmedizin, Germany.

Stephan Ripke (S)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, USA; and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, USA.

Tim B Bigdeli (TB)

Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, USA; and VA NY Harbor Healthcare System, USA.

Frederike Stein (F)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Tina Meller (T)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany; and Center for Mind, Brain and Behavior (CMBB), Germany.

Susanne Meinert (S)

Institute for Translational Psychiatry, Westfälische Wilhelms-Universität Münster, Germany; and Institute for Translational Neuroscience, University of Münster, Germany.

Helena Pelin (H)

International Max Planck Research School for Translational Psychiatry, Germany; and Max Planck Institute of Psychiatry, Germany.

Fabian Streit (F)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.

Sergi Papiol (S)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; and Centro de Investigación Biomedica en Red de Salud Mental (CIBERSAM), Spain.

Mark J Adams (MJ)

Division of Psychiatry, University of Edinburgh, UK.

Rolf Adolfsson (R)

Department of Clinical Sciences, Medical Faculty, Umeå University, Sweden.

Kristina Adorjan (K)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; and Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany.

Ingrid Agartz (I)

Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Sweden; Department of Psychiatric Research, Diakonhjemmet Hospital, Norway; and NORMENT Centre, Division of Mental Health and Addiction, Institute of Clinical Medicine, University of Oslo, Norway.

Sofie R Aminoff (SR)

Division of Mental Health and Addiction, Oslo University Hospital, Norway; and NORMENT Centre, Inst of Clinical Medicine, University of Oslo, Norway.

Heike Anderson-Schmidt (H)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Germany.

Ole A Andreassen (OA)

NORMENT Centre, Inst of Clinical Medicine, University of Oslo, Norway; and Division of Mental Health and Addiction, Oslo University Hosptial, Norway.

Raffaella Ardau (R)

Unit of Clinical Pharmacology, University Hospital Agency of Cagliari, Italy.

Jean-Michel Aubry (JM)

Faculty of medicine, University of Geneva, Switzerland; and Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.

Ceylan Balaban (C)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.

Nicholas Bass (N)

Division of Psychiatry, University College London, UK.

Bernhard T Baune (BT)

Department of Psychiatry, University of Münster, Germany; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Australia; and Discipline of Psychiatry, Adelaide Medical School, The University of Adelaide, Australia.

Frank Bellivier (F)

Universite de Paris, France; INSERM UMRS 1144, France; and DMU Neurosciences, GHU Lariboisière Fernand Widal, Departement de Psychiatrie, APHP, France.

Antoni Benabarre (A)

Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain.

Susanne Bengesser (S)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Austria.

Wade H Berrettini (WH)

Psychiatry, University of Pennsylvania, USA.

Marco P Boks (MP)

Psychiatry, UMC Utrecht Brain Center, the Netherlands.

Evelyn J Bromet (EJ)

Department of Psychiatry, Stony Brook University, USA.

Katharina Brosch (K)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Monika Budde (M)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

William Byerley (W)

Psychiatry, University of California San Francisco, USA.

Pablo Cervantes (P)

Department of Psychiatry, McGill University, Canada.

Catina Chillotti (C)

Unit of Clinical Pharmacology, University Hospital Agency of Cagliari, Italy.

Sven Cichon (S)

Department of Biomedicine, University of Basel, Switzerland; Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Germany; Institute of Medical Genetics and Pathology, University Hospital Basel, Switzerland; and Institute of Neuroscience and Medicine (INM-1), Research Centre Julich, Germany.

Scott R Clark (SR)

Discipline of Psychiatry, University of Adelaide, Australia; and Bazil Hetzel Institute, Australia.

Ashley L Comes (AL)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; and International Max Planck Research School for Translational Psychiatry, Germany.

Aiden Corvin (A)

Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College Dublin, Ireland.

William Coryell (W)

University of Iowa Hospitals and Clinics, USA.

Nick Craddock (N)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

David W Craig (DW)

Translational Genomics, USC, USA.

Paul E Croarkin (PE)

Department of Psychiatry and Psychology, Mayo Clinic, USA.

Cristiana Cruceanu (C)

Department of Translational Research, Max Planck Institute of Psychiatry, Germany.

Piotr M Czerski (PM)

Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poland.

Nina Dalkner (N)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Austria.

Udo Dannlowski (U)

Institute for Translational Psychiatry, Westfälische Wilhelms-Universität Münster, Germany.

Franziska Degenhardt (F)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Germany; and Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Germany.

Maria Del Zompo (M)

Department of Biomedical Science, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Italy; and Unit of Clinical Pharmacology, University Hospital Agency of Cagliari, Italy.

J Raymond DePaulo (JR)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, USA.

Srdjan Djurovic (S)

Department of Medical Genetics, Oslo University Hospital Ullevål, Norway; and NORMENT, Department of Clinical Science, University of Bergen, Norway.

Howard J Edenberg (HJ)

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, USA.

Mariam Al Eissa (MA)

Division of Psychiatry, University College London, UK.

Torbjørn Elvsåshagen (T)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Norway.

Bruno Etain (B)

Universite de Paris, France; INSERM UMRS 1144, France; and DMU Neurosciences, GHU Lariboisière Fernand Widal, Departement de Psychiatrie, APHP, France.

Ayman H Fanous (AH)

Department of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, USA; and VA NY Harbor Healthcare System, USA.

Frederike Fellendorf (F)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Austria.

Alessia Fiorentino (A)

Division of Psychiatry, University College London, UK.

Andreas J Forstner (AJ)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Germany; and Centre for Human Genetics, University of Marburg, Germany.

Mark A Frye (MA)

Department of Psychiatry and Psychology, Mayo Clinic, USA.

Janice M Fullerton (JM)

Neuroscience Research Australia, Australia; and School of Medical Sciences, University of New South Wales, Australia.

Katrin Gade (K)

Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Germany.

Julie Garnham (J)

Nova Scotia Health Authority, Canada.

Elliot Gershon (E)

Department of Psychiatry and Behavioral Neuroscience, University of Chicago, USA; and Department of Human Genetics, University of Chicago, USA.

Michael Gill (M)

Department of Psychiatry & Trinity Translational Medicine Institute, Trinity College Dublin, Ireland.

Fernando S Goes (FS)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, USA.

Katherine Gordon-Smith (K)

Psychological Medicine, University of Worcester, UK.

Paul Grof (P)

Mood Disorders Centre of Ottawa, Canada; and Department of Psychiatry, University of Toronto, Canada.

Jose Guzman-Parra (J)

Mental Health Department, University Regional Hospital, Biomedicine Institute (IBIMA), Spain.

Tim Hahn (T)

Institute for Translational Psychiatry, Westfälische Wilhelms-Universität Münster, Germany.

Roland Hasler (R)

Cell Biology, SUNY Downstate Medical Center College of Medicine, USA; and Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, USA.

Maria Heilbronner (M)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

Urs Heilbronner (U)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

Stephane Jamain (S)

Universite Paris Est Creteil, France; and INSERM U 955, Neuropsychiatrie Translationnelle, France.

Esther Jimenez (E)

Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain.

Ian Jones (I)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Lisa Jones (L)

Psychological Medicine, University of Worcester, UK.

Lina Jonsson (L)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden.

Rene S Kahn (RS)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, USA.

John R Kelsoe (JR)

Department of Psychiatry, University of California San Diego, USA.

James L Kennedy (JL)

Department of Psychiatry, University of Toronto, Canada; The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; and Institute of Medical Science, University of Toronto, Canada.

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

George Kirov (G)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Sarah Kittel-Schneider (S)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany; and Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital Wurzburg, Germany.

Farah Klöhn-Saghatolislam (F)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

James A Knowles (JA)

Cell Biology, SUNY Downstate Medical Center College of Medicine, USA; and Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, USA.

Thorsten M Kranz (TM)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.

Trine Vik Lagerberg (TV)

NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hosptial, Norway.

Mikael Landen (M)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden; and Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden.

William B Lawson (WB)

Department of Psychiatry and Behavioral Sciences, Howard University Hospital, USA.

Marion Leboyer (M)

Universite Paris Est Creteil, France; and INSERM U 955, Neuropsychiatrie Translationnelle, France.

Qingqin S Li (QS)

Neuroscience, Janssen Research & Development, USA.

Mario Maj (M)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Italy.

Dolores Malaspina (D)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, USA; and Department of Genetics & Genomics, Icahn School of Medicine at Mount Sinai, USA.

Mirko Manchia (M)

Unit of Psychiatry, Department of Medical Sciences and Public Health, University of Cagliari, Italy and Department of Pharmacology, Dalhousie University, Canada.

Fermin Mayoral (F)

Mental Health Department, University Regional Hospital, Biomedicine Institute (IBIMA), Spain.

Susan L McElroy (SL)

Research Institute, Lindner Center of HOPE, USA.

Melvin G McInnis (MG)

Department of Psychiatry, University of Michigan, USA.

Andrew M McIntosh (AM)

Division of Psychiatry, University of Edinburgh, UK.

Helena Medeiros (H)

Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, USA.

Ingrid Melle (I)

NORMENT Centre, Division of Mental Health and Addiction, Institute of Clinical Medicine and Diakonhjemmet Hospital, University of Oslo, Norway; and Division of Mental Health and Addiction, Oslo University Hospital, Norway.

Vihra Milanova (V)

Psychiatric Clinic, Alexander University Hospital, Bulgaria.

Philip B Mitchell (PB)

School of Psychiatry, University of New South Wales, Australia.

Palmiero Monteleone (P)

Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Italy.

Alessio Maria Monteleone (AM)

Department of Psychiatry, University of Campania 'Luigi Vanvitelli', Italy.

Markus M Nöthen (MM)

Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Germany.

Tomas Novak (T)

National Institute of Mental Health, Czech Republic.

John I Nurnberger (JI)

Psychiatry, Indiana University School of Medicine, USA.

Niamh O'Brien (N)

Division of Psychiatry, University College London, UK.

Kevin S O'Connell (KS)

Division of Mental Health and Addiction, Oslo University Hospital, Norway; and NORMENT Centre, Inst of Clinical Medicine, University of Oslo, Norway.

Claire O'Donovan (C)

Department of Psychiatry, Dalhousie University, Canada.

Michael C O'Donovan (MC)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Nils Opel (N)

Institute for Translational Psychiatry, Westfälische Wilhelms-Universität Münster, Germany.

Abigail Ortiz (A)

Department of Psychiatry, University of Toronto, Toronto, Canada; and Centre for Addiction and Mental Health, Toronto, Canada.

Michael J Owen (MJ)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Erik Pålsson (E)

Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Sweden.

Carlos Pato (C)

Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, USA.

Michele T Pato (MT)

Institute for Genomic Health, SUNY Downstate Medical Center College of Medicine, USA.

Joanna Pawlak (J)

Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poland.

Julia-Katharina Pfarr (JK)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Claudia Pisanu (C)

Department of Biomedical Science, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Italy.

James B Potash (JB)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, USA.

Mark H Rapaport (MH)

Department of Psychiatry and Behavioral Sciences, Emory University, USA.

Daniela Reich-Erkelenz (D)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

Andreas Reif (A)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Germany.

Eva Reininghaus (E)

Department of Psychiatry and Psychotherapeutic Medicine, Medical University Graz, Austria.

Jonathan Repple (J)

Institute for Translational Psychiatry, Westfälische Wilhelms-Universität Münster, Germany.

Hélène Richard-Lepouriel (H)

Department of Psychiatry, Geneva University Hospitals, Switzerland.

Marcella Rietschel (M)

Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.

Kai Ringwald (K)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Gloria Roberts (G)

School of Psychiatry, University of New South Wales, Australia.

Guy Rouleau (G)

Montreal Neurological Institute, Canada and Department of Neurology, McGill University, Canada.

Sabrina Schaupp (S)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany.

William A Scheftner (WA)

Department of Psychiatry, Rush Medical College, USA.

Simon Schmitt (S)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Germany.

Peter R Schofield (PR)

Neuroscience Research Australia, Australia; and School of Medical Sciences, University of New South Wales, Australia.

K Oliver Schubert (KO)

Discipline of Psychiatry, University of Adelaide, Australia; and Northern Adelaide Mental Health Service, SA Health, Australia.

Eva C Schulte (EC)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; and Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany.

Barbara Schweizer (B)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, USA.

Fanny Senner (F)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; and Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany.

Giovanni Severino (G)

Department of Biomedical Science, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Italy.

Sally Sharp (S)

Division of Psychiatry, University College London, UK.

Claire Slaney (C)

Nova Scotia Health Authority, Canada.

Olav B Smeland (OB)

Division of Mental Health and Addiction, Oslo University Hospital, Norway; and NORMENT Centre, Inst of Clinical Medicine, University of Oslo, Norway.

Janet L Sobell (JL)

Psychiatry and the Behavioral Sciences, University of Southern California, USA.

Alessio Squassina (A)

Department of Psychiatry, Dalhousie University, Canada; and Department of Biomedical Science, Section of Neuroscience & Clinical Pharmacology, University of Cagliari, Italy.

Pavla Stopkova (P)

National Institute of Mental Health, Czech Republic.

John Strauss (J)

Department of Psychiatry, University of Toronto, Canada; The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; and Institute of Medical Science, University of Toronto, Canada.

Alfonso Tortorella (A)

Department of Psychiatry, University of Perugia, Italy.

Gustavo Turecki (G)

Department of Psychiatry, McGill University, Canada; and Douglas Institute, McGill University, Canada.

Joanna Twarowska-Hauser (J)

Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poland.

Marin Veldic (M)

Department of Psychiatry and Psychology, Mayo Clinic, USA.

Eduard Vieta (E)

Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Spain.

John B Vincent (JB)

Department of Psychiatry, University of Toronto, Canada; The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; and Institute of Medical Science, University of Toronto, Canada.

Wei Xu (W)

Dalla Lana School of Public Health, Biostatistics Division, University of Toronto, Canada.

Clement C Zai (CC)

Department of Psychiatry, University of Toronto, Canada; The Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; Institute of Medical Science, University of Toronto, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Canada; and Harvard T.H. Chan School of Public Health, USA.

Peter P Zandi (PP)

Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, USA.

Arianna Di Florio (A)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, UK.

Jordan W Smoller (JW)

Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry and Center for Genomic Medicine, Massachusetts General Hospital, USA; and Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, USA.

Joanna M Biernacka (JM)

Department of Psychiatry and Psychology, Mayo Clinic, USA; and Department of Health Sciences Research, Mayo Clinic, USA.

Francis J McMahon (FJ)

Human Genetics Branch, Intramural Research Program, National Institute of Mental Health, USA.

Martin Alda (M)

National Institute of Mental Health, Czech Republic; and Department of Psychiatry, Dalhousie University, Canada.

Bertram Müller-Myhsok (B)

Max Planck Institute of Psychiatry, Germany.

Nikolaos Koutsouleris (N)

Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany; Max Planck Institute of Psychiatry, Germany; and Institute of Psychiatry, Psychology and Neuroscience, Kings College London, UK.

Peter Falkai (P)

Department of Psychiatry and Psychotherapy, University Hospital Munich, Germany.

Nelson B Freimer (NB)

Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, USA; and Human Genetics, University of California Los Angeles, USA.

Till F M Andlauer (TFM)

Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Germany.

Thomas G Schulze (TG)

Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Germany; Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany; Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Germany; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, USA; and Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, USA.

Roel A Ophoff (RA)

Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, USA; Human Genetics, University of California Los Angeles, USA; and Psychiatry, Erasmus University Medical Center, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH